Answers are grounded in this paper and cite their sources.
Review summarizes endothelium-derived vasoactive mediators controlling vascular tone, highlighting the opposing roles of nitric oxide and endothelin.
The nonthrombogenic and high solute and water permeability properties of the vascular endothelium have long been recog- nized as essential components of normal microvascular integ- rity. In addition to the more recent recognition of other hemo- static as well as proproliferative and cytoadhesive properties, the past decade has witnessed a growing awareness that this endothelial monolayer is also capable of intrinsic modulation of vascular tone by elaborating several potent vasoactive sub- stances. Two impressive vasorelaxants are prostacyclin and endothelium-derived relaxation factor (EDRF),' the latter at least in part composed of nitric oxide (NO). In addition, vascu- lar endothelium has been shown recently to synthesize a novel polypeptide, termed endothelin, which exhibits potent vaso- constrictor properties. Prostacyclin, a major metabolite of the cyclooxygenase pathway in vessel walls and the subject of in- tense study for more than a decade, has recently been reviewed (1). Due to space constraints, this brief review2 will therefore focus on other recently described endothelium-dependent va- soactive mediators, particularly NO and endothelin.
No takes yet. Share an insight, caveat, or question.
Brenner et al. (1989) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: